Canada markets open in 8 hours 4 minutes

Chromocell Therapeutics Corporation (CHRO)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.7700-0.0200 (-1.12%)
At close: 03:16PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
199.934
Operating Expenses
Research Development
2,579
2,579
391.73
209.047
138.585
Selling General and Administrative
4,283
4,283
1,926
629.949
1,415
Total Operating Expenses
6,862
6,862
2,318
838.996
1,554
Operating Income or Loss
-6,862
-6,862
-2,318
-838.996
-1,354
Interest Expense
518.509
518.509
140.43
0.253
1.676
Total Other Income/Expenses Net
-
-
-
243.862
694.959
Income Before Tax
-7,381
-7,381
-2,459
-595.387
-660.584
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-7,381
-7,381
-2,459
-595.387
-660.584
Net Income
-7,381
-7,381
-2,459
-595.387
-660.584
Net Income available to common shareholders
-7,381
-7,381
-2,459
-595.387
-660.584
Basic EPS
0.03
-
-0.26
-0.10
-0.07
Diluted EPS
0.03
-
-0.26
-0.10
-0.07
Basic Average Shares
15,564
-
9,287
5,768
9,287
Diluted Average Shares
15,564
-
9,287
5,768
9,287